Changes in cognition and behaviour in amyotrophic lateral sclerosis: Nature of impairment and implications for assessment

The Lancet Neurology

Volumn 12, Issue 4, 2013, Pages 368-380

  Goldstein, Laura H ^a   Abrahams, Sharon ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FUSED IN SARCOMA PROTEIN; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; BEHAVIOR CHANGE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; EMOTION; EUROPE; EXECUTIVE FUNCTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE MUTATION; GENETIC VARIABILITY; HUMAN; INCIDENCE; LANGUAGE; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOCIAL COGNITION; THEORY OF MIND; WORKING MEMORY;

AMYOTROPHIC LATERAL SCLEROSIS; COGNITION DISORDERS; HUMANS; NEUROPSYCHOLOGICAL TESTS; SOCIAL BEHAVIOR;

EID: 84875245319     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70026-7     Document Type: Review

References (140)

1. Logroscino G, Traynor BJ, Hardiman O, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2010, 81:385-390.
2. Alonso A, Logroscino G, Jick SS, Hernan MA Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol 2009, 16:745-751.
3. Manjaly ZR, Scott KM, Abhinav K, et al. The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph Lateral Scler 2010, 11:439-442.
4. Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol 2012, 19:360-375.
5. Bedlack RS Amyotrophic lateral sclerosis: current practice and future treatments. Curr Opin Neurol 2010, 23:524-529.
6. Byrne S, Elamin M, Bede P, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 2012, 11:232-240.
7. Vance C, Rogelj B, Hortobagyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
8. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
9. Phukan J, Pender NP, Hardiman O Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 2007, 6:994-1003.
10. Geser F, Lee VMY, Trojanowski JQ Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology 2010, 30:103-112.
11. Mitsuyama Y Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases. J Neurol Neurosurg Psychiatry 1984, 47:953-959.
12. Wikström JPA, Palo J, Sulkava R, Haltia M Classic amyotrophic lateral sclerosis with dementia. Arch Neurol 1982, 39:681-683.
13. Ziegler LH Psychotic and emotional phenomena associated with amyotrophic lateral sclerosis. Arch Neurol Psychiatry 1930, 24:930-936.
14. David AS, Gillham RA Neuropsychological study of motor neuron disease. Psychosomatics 1986, 27:441-445.
15. Gallassi R, Montagna P, Morreale A, et al. Neuropsychological, electroencephalogram and brain computed tomography findings in motor neuron disease. Eur Neurol 1989, 29:115-120.
16. Kew JJ, Goldstein LH, Leigh PN, et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. Brain 1993, 116:1399-1423.
17. Abrahams S, Goldstein LH, Al Chalabi A, et al. Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1997, 62:464-472.
18. Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grise D, Goldstein LH Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia 2000, 38:734-747.
19. Abrahams S, Goldstein LH, Suckling J, et al. Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol 2005, 253:321-331.
20. Chari G, Shaw PJ, Sahgal A Nonverbal visual attention, but not recognition memory or learning processes are impaired in motor neurone disease. Neuropsychologia 1996, 34:377-385.
21. Abe K, Fujimura H, Toyooka K, Sakoda S, Yorifuji S, Yanagihara T Cognitive function in amyotrophic lateral sclerosis. J Neurol Sci 1997, 148:95-100.
22. Talbot PR, Goulding PJ, Lloyd JJ, Snowden JS, Neary D, Testa HJ Inter-relation between " classic" motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry 1995, 58:541-547.
23. Raaphorst J, De Visser M, Linssen WHJP, De Haan RJ, Schmand B The cognitive profile of amyotrophic lateral sclerosis: a meta-analysis. Amyotroph Lateral Scler 2010, 11:27-37.
24. Massman PJ, Sims J, Cooke N, Haverkamp LJ, Appel V, Appel SH Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1996, 61:450-455.
25. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005, 65:586-590.
26. Witgert M, Salamone AR, Strutt AM, et al. Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. Eur J Neurol 2010, 17:103-110.
27. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B Are amyotrophic lateral sclerosis patients cognitively normal?. Neurology 2003, 60:1094-1097.
28. Gordon PH, Delgadillo D, Piquard A, et al. The range and clinical impact of cognitive impairment in French patients with ALS: a cross-sectional study of neuropsychological test performance. Amyotroph Lateral Scler 2011, 12:372-378.
29. Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2011, 76:1263-1269.
30. Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2012, 83:102-108.
31. Girardi A, MacPherson SE, Abrahams S Deficits in emotional and social cognition in amyotrophic lateral sclerosis. Neuropsychology 2011, 25:53-65.
32. Meier SL, Charleston AJ, Tippett LJ Cognitive and behavioural deficits associated with the orbitomedial prefrontal cortex in amyotrophic lateral sclerosis. Brain 2010, 133:3444-3457.
33. Lillo P, Savage S, Mioshi E, Kiernan MC, Hodges JR Amyotrophic lateral sclerosis and frontotemporal dementia: a behavioural and cognitive continuum. Amyotroph Lateral Scler 2012, 13:102-109.
34. Abrahams S, Goldstein LH, Kew JJ, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain 1996, 119:2105-2120.
35. Abrahams S, Goldstein LH, Simmons A, et al. Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain 2004, 127:1507-1517.
36. Donaghy C, Pinnock R, Abrahams S, et al. Ocular fixation instabilities in motor neurone disease: a marker of frontal lobe dysfunction?. J Neurol 2009, 256:420-426.
37. Donaghy C, Pinnock R, Abrahams S, et al. Slow saccades in bulbar-onset motor neurone disease. J Neurol 2010, 257:1134-1140.
38. Lepow L, Van Sweringen J, Strutt AM, et al. Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis. J Clin Exp Neuropsychol 2010, 32:913-922.
39. Elman L, Libon D, Gunawardena D, et al. Deficits in concept formation in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010, 11:146.
40. Stukovnik V, Zidar J, Podnar S, Repovs G Amyotrophic lateral sclerosis patients show executive impairments on standard neuropsychological measures and an ecologically valid motor-free test of executive functions. J Clin Exp Neuropsychol 2010, 32:1095-1109.
41. Volpato C, Piccione F, Silvoni S, et al. Working memory in amyotrophic lateral sclerosis: auditory event-related potentials and neuropsychological evidence. J Clin Neurophysiol 2010, 27:198-206.
42. Munte TF, Troger M, Nusser I, et al. Recognition memory deficits in amyotrophic lateral sclerosis assessed with event-related brain potentials. Act Neurol Scand 1998, 98:110-115.
43. Hanagasi HA, Gurvit IH, Ermutlu N, et al. Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsychological investigation and event-related potentials. Cogn Brain Res 2002, 14:234-244.
44. Paulus KS, Magnano I, Piras MR, et al. Visual and auditory event-related potentials in sporadic amyotrophic lateral sclerosis. Clin Neurophysiol 2002, 13:853-861.
45. Baddeley AD Working memory 1986, Oxford University Press, Oxford.
46. Hammer A, Vielhaber S, Rodriguez-Fornells A, Mohammadi B, Muente TF A neurophysiological analysis of working memory in amyotrophic lateral sclerosis. Brain Res 2011, 1421:90-99.
47. Conway ARA, Kane MJ, Bunting MF, Hambrick DZ, Wilhelm O, Engle RW Working memory span tasks: a methodological review and user's guide. Psychonom Bull Rev 2005, 12:769-786.
48. Raggi A, Iannaccone S, Cappa SF Event-related brain potentials in amyotrophic lateral sclerosis: a review of the international literature. Amyotroph Lateral Scler 2010, 11:16-26.
49. Bak TH, O'Donovan DG, Xuereb JH, Boniface S, Hodges JR Selective impairment of verb processing associated with pathological changes in Brodmann areas 44 and 45 in the motor neurone disease-dementia-aphasia syndrome. Brain 2001, 124:1-20.
50. Rakowicz WP, Hodges JR Dementia and aphasia in motor neuron disease: an underrecognised association?. J Neurol Neurosurg Psychiatry 1998, 65:881-889.
51. Cobble M Language impairment in motor neurone disease. J Neurol Sci 1998, 160(suppl):52.
52. Grossman M, Anderson C, Khan A, Avants B, Elman L, McCluskey L Impaired action knowledge in amyotrophic lateral sclerosis. Neurology 2008, 71:1396-1401.
53. Taylor LJ, Brown RG, Tsermentseli S, et al. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis?. J Neurol Neurosurg Psychiatry 2012, published online Oct 2. 10/1136/jnnp-2012-303526.
54. Van Der Hulst EJ, Abrahams S, Bak TH The nature of language deficits in ALS: semantic impairments in action sequencing. Amyotroph Lateral Scler 2010, 11:32-33.
55. Hillis AE, Oh S, Ken L Deterioration of naming nouns versus verbs in primary progressive aphasia. Ann Neurol 2004, 55:268-275.
56. Bak TH, Hodges JR Kissing and dancing-a test to distinguish the lexical and conceptual contributions to noun/verb and action/object dissociation. Preliminary results in patients with frontotemporal dementia. J Neurolinguistics 2003, 16:169-181.
57. Bak TH, Chandran S What wires together dies together: verbs, actions and neurodegeneration in motor neuron disease. Cortex 2012, 48:936-944.
58. Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009, 10:131-146.
59. Satoh M, Takeda K, Kuzuhara S Agraphia in intellectually normal Japanese patients with ALS: omission of kana letters. J Neurol 2009, 256:1455-1460.
60. Ichikawa H, Hieda S, Ohno H, et al. Kana versus kanji in amyotrophic lateral sclerosis: a clinicoradiological study of writing errors. Eur Neurol 2010, 64:148-155.
61. Ichikawa H, Ohno H, Murakami H, Ohnaka Y, Kawamura M Writing error may be a predictive sign for impending brain atrophy progression in amyotrophic lateral sclerosis: a preliminary study using x-ray computed tomography. Eur Neurol 2011, 65:346-351.
62. Abrahams S Executive dysfunction in ALS is not the whole story. J Neurol Neurosurg Psychiatry 2012, published online Oct 31. DOI:10.111136/jnnp-2012-303851.
63. Abrahams S Social cognition in amyotrophic lateral sclerosis. Neurodegen Dis Management 2011, 1:397-405.
64. Cavallo M, Adenzato M, MacPherson SE, Karwig G, Enrici I, Abrahams S Evidence of social understanding impairment in patients with amyotrophic lateral sclerosis. PLoS One 2011, 6:e25948.
65. Palmieri A, Naccarato M, Abrahams S, et al. Right hemisphere dysfunction and emotional processing in ALS: an fMRI study. J Neurol 2010, 257:1970-1978.
66. Cuddy M, Papps BJ, Thambisetty M, Leigh PN, Goldstein LH Processing for emotional and neutral material in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2012, 13:592-598.
67. Gibbons ZC, Richardson A, Neary D, Snowden JS Behaviour in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2008, 9:67-74.
68. Zimmerman ME, Brickman AM, Paul RH, et al. The relationship between frontal gray matter volume and cognition varies across the healthy adult lifespan. Am J Geriatr Psychiatry 2006, 14:823-833.
69. Schmolck H, Mosnik D, Schulz P Rating the approachability of faces in ALS. Neurology 2007, 69:2232-2235.
70. Papps B, Abrahams S, Wicks P, Leigh PN, Goldstein LH Changes in memory for emotional material in amyotrophic lateral sclerosis (ALS). Neuropsychologia 2005, 43:1107-1114.
71. Lulé D, Kurt A, Jurgens R, et al. Emotional responding in amyotrophic lateral sclerosis. J Neurol 2005, 252:1517-1524.
72. Gibbons ZC, Snowden JS, Thompson JC, Happe F, Richardson A, Neary D Inferring thought and action in motor neurone disease. Neuropsychologia 2007, 45:1196-1207.
73. Grace J, Malloy PF Frontal systems behavior scale 2002, Psychological Assessment Resources, Florida.
74. Kertesz A, Davidson W, Fox H Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 1997, 24:29-36.
75. Grossman A, Woolley-Levine S, Bradley W, Miller R Detecting neurobehavioral changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2007, 8:56-61.
76. Wicks P, Abrahams S, Papps B, et al. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis. J Neurol 2009, 256:234-241.
77. Chio A, Vignola A, Mastro E, et al. Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol 2010, 17:1298-1303.
78. Raaphorst J, Beeldman E, Schmand B, et al. The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALS. Neurology 2012, 79:1377-1383.
79. Woolley SC, Moore DH, Katz JS Insight in ALS: awareness of behavioral change in patients with and without FTD. Amyotroph Lateral Scler 2010, 11:52-56.
80. Terada T, Obi T, Yoshizumi M, Murai T, Miyajima H, Mizoguchi K Frontal lobe-mediated behavioral changes in amyotrophic lateral sclerosis: are they independent of physical disabilities?. J Neurol Sci 2011, 309:136-140.
81. Flaherty-Craig CV, Brothers A, Yang C, Svoboda R, Simmons Z Declines in problem solving and anosognosia in amyotrophic lateral sclerosis: application of Guilford's structure of intellect theory. Cogn Behav Neurol 2011, 24:26-34.
82. Murphy JM, Henry RG, Langmore S, Kramer JH, Miller BL, Lomen-Hoerth C Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 2007, 64:530-534.
83. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011, 134:2456-2477.
84. Masellis M, Zinman L, Black SE More than just 'frontal': disentangling behavioural disturbances in amyotrophic lateral sclerosis. Eur J Neurol 2010, 17:5-7.
85. Grossman AB, Levin BE, Bradley WG Premorbid personality characteristics of patients with ALS. Amyotroph Lateral Scler Other Mot Neuron Dis 2006, 7:27-31.
86. Urwin H, Josephs KA, Rohrer JD, et al. FUS pathology defines the majority of tau-and TDP-43-negative frontotemporal lobar degeneration. Act Neuropathol 2010, 120:33-41.
87. Snowden JS, Thompson JC, Stopford CL, et al. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain 2011, 134:2478-2492.
88. Snowden JS, Rollinson S, Thompson JC, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9orf72 mutations. Brain 2012, 135:693-708.
89. Lillo P, Mioshi E, Zoing MC, Kiernan MC, Hodges JR How common are behavioural changes in amyotrophic lateral sclerosis?. Amyotroph Lateral Scler 2011, 12:45-51.
90. Lillo P, Garcin B, Hornberger M, Bak TH, Hodges JR Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurology 2010, 67:826-830.
91. Byrne S, Elamin M, Bede P, Hardiman O Absence of consensus in diagnostic criteria for familial neurodegenerative diseases. J Neurol Neurosurg Psychiatry 2012, 83:365-387.
92. Simon-Sanchez J, Dopper EGP, Cohn-Hokke PE, et al. The clinical and pathological phenotype of C9orf72 hexanucleotide repeat expansions. Brain 2012, 135:723-735.
93. Mahoney CJ, Beck J, Rohrer JD, et al. Frontotemporal dementia with the C9orf72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012, 135:736-750.
94. van Rheenen W, van Blitterswijk M, Huisman MHB, et al. Hexanucleotide repeat expansions in C9orf72 in the spectrum of motor neuron diseases. Neurology 2012, 79:878-882.
95. Kilani M, Micallef J, Soubrouillard C, et al. A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Dis 2004, 5:46-54.
96. Abrahams S, Leigh PN, Goldstein LH Cognitive change in ALS: a prospective study. Neurology 2005, 64:1222-1226.
97. Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, et al. Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis: a longitudinal study in 52 patients. J Neurol 2005, 25:772-781.
98. Robinson KM, Lacey SC, Grugan P, Glosser G, Grossman M, McCluskey LF Cognitive functioning in sporadic amyotrophic lateral sclerosis: a six month longitudinal study. J Neurol Neurosurg Psychiatry 2006, 77:668-670.
99. Gordon PH, Goetz RR, Rabkin JG, et al. A prospective cohort study of neuropsychological test performance in ALS. Amyotroph Lateral Scler 2010, 11:312-320.
100. Moglia C, Calvo A, Manera U, et al. Executive dysfunction score of the frontal behavior system scale (FrSBe) is independently related to ALS outcome. Eur J Neurol 2011, 18:221.
101. Rusina R, Ridzon P, Kulist'Ak P, et al. Relationship between ALS and the degree of cognitive impairment, markers of neurodegeneration and predictors for poor outcome. A prospective study. Eur J Neurol 2010, 17:23-30.
102. Olney RK, Murphy J, Forshew D, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology 2005, 65:1774-1777.
103. Tsermentseli S, Leigh PN, Goldstein LH The anatomy of cognitive impairment in amyotrophic lateral sclerosis: more than frontal lobe dysfunction. Cortex 2012, 48:166-182.
104. 11C-flumazenil PET study. Amyotroph Lateral Scler 2008, 9:43-49.
105. Sarro L, Agosta F, Canu E, et al. Cognitive functions and white matter tract damage in amyotrophic lateral sclerosis: a diffusion tensor tractography study. Am J Neuroradiol 2011, 32:1866-1872.
106. Goldstein LH, Newsom-Davis IC, Bryant V, Brammer M, Leigh PN, Simmons A Altered patterns of cortical activation in ALS patients during attention and cognitive response inhibition tasks. J Neurology 2011, 258:2186-2198.
107. Lulé D, Diekmann V, Anders S, et al. Brain responses to emotional stimuli in patients with amyotrophic lateral sclerosis (ALS). J Neurol 2007, 254:519-527.
108. Woolley SC, Zhang Y, Schuff N, Weiner MW, Katz JS Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRI. Amyotroph Lateral Scler 2011, 12:52-58.
109. Tsujimoto M, Senda J, Ishihara T, et al. Behavioral changes in early ALS correlate with voxel-based morphometry and diffusion tensor imaging. J Neurol Sci 2011, 307:34-40.
110. Abrahams S Cognition and the clinic. Amyotroph Lateral Scler Frontotemp Degen 2013, 14:3-5.
111. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998, 51:1546-1554.
112. Rascovsky K, Hodges JR, Kipps CM, et al. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alz Dis Assoc Disord 2007, 21:S14-S18.
113. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR The Addenbrooke's cognitive examination revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriat Psychiatry 2006, 21:1078-1085.
114. Flaherty-Craig C, Eslinger P, Stephens B, Simmons Z A rapid screening battery to identify frontal dysfunction in patients with ALS. Neurology 2006, 67:2070-2072.
115. Flaherty-Craig C, Brothers A, Dearman B, Eslinger P, Simmons Z Penn State screen exam for the detection of frontal and temporal dysfunction syndromes: application to ALS. Amyotroph Lateral Scler 2009, 10:107-112.
116. Wicks P, Abrahams S, Leigh PN, Goldstein LH A rapid screening battery to identify frontal dysfunction in patients with ALS. Neurology 2007, 69:118-119.
117. Gordon PH, Wang Y, Doorish C, et al. A screening assessment of cognitive impairment in patients with ALS. Amyotroph Lateral Scler 2007, 8:362-365.
118. Woolley SC, York MK, Moore DH, et al. Detecting frontotemporal dysfunction in ALS: utility of the ALS cognitive behavioral screen (ALS-CBS). Amyotroph Lateral Scler 2010, 11:303-311.
119. Dubois B, Slachevsky A, Litvan I, Pillon B The FAB: a frontal assessment battery at bedside. Neurology 2000, 55:1621-1626.
120. Heidler-Gary J, Hillis AE Distinctions between the dementia in amyotrophic lateral sclerosis with frontotemporal dementia and the dementia of Alzheimer's disease. Amyotroph Lateral Scler 2007, 8:276-282.
121. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994, 44:2308-2314.
122. Oskarsson B, Quan D, Rollins YD, Neville HE, Ringel SP, Arciniegas DB Using the frontal assessment battery to identify executive function impairments in amyotrophic lateral sclerosis: a preliminary experience. Amyotroph Lateral Scler 2010, 11:244-247.
123. Floris G, Borghero G, Chio A, et al. Cognitive screening in patients with amyotrophic lateral sclerosis in early stages. Amyotroph Lateral Scler 2012, 13:95-101.
124. Goldstein LH Behavioural change in amytrophic lateral sclerosis. Amyotrophic lateral sclerosis and the frontotemporal dementias 2012, 137-154. Oxford University Press, Oxford. M.J. Strong (Ed.).
125. Palmieri A, Abrahams S, Soraru G, et al. Emotional lability in MND: relationship to cognition and psychopathology and impact on caregivers. J Neurol Sci 2009, 278:16-20.
126. Wicks P, Abrahams S, Masi D, Hejda-Forde S, Leigh PN, Goldstein LH Prevalence of depression in a 12-month consecutive sample of patients with ALS. Eur J Neurol 2007, 14:993-1001.
127. Taylor L, Wicks P, Leigh PN, Goldstein LH Prevalence of depression in amyotrophic lateral sclerosis and other motor disorders. Eur J Neurol 2010, 17:1047-1053.
128. Gibbons CJ, Mills RJ, Thornton EW, et al. Rasch analysis of the hospital anxiety and depression scale (hads) for use in motor neurone disease. Health Qual Life Outcomes 2011, 9:82.
129. Newsom-Davis IC, Lyall RA, Leigh PN, Moxham J, Goldstein LH The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study. J Neurol Neurosurg Psychiatry 2001, 71:482-487.
130. Mustfa N, Walsh E, Bryant V, et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology 2006, 66:1211-1217.
131. Kim SM, Lee KM, Hong YH, et al. Relation between cognitive dysfunction and reduced vital capacity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007, 78:1387-1389.
132. Sterling LE, Jawaid A, Salamone AR, et al. Association between dysarthria and cognitive impairment in ALS: a prospective study. Amyotroph Lateral Scler 2010, 11:46-51.
133. Powell JE The effects of prescribed and psychoactive drug use on cognitive functioning. Clinical neuropsychology 2013, 105-128. Wiley-Blackwell, Chichester. 2nd edn. L. Goldstein, J.E. McNeil (Eds.).
134. Goldstein LH, Adamson M, Jeffrey L, et al. The psychological impact of MND on patients and carers. J Neurol Sci 1998, 160(suppl):S114-S121.
135. Goldstein LH, Atkins L, Landau S, Brown RG, Leigh PN Psychological distress and burden in carers of people with ALS: a longitudinal study. Psychol Med 2006, 36:865-876.
136. Wicks P, Frost J ALS patients request more information about cognitive symptoms. Eur J Neurology 2008, 15:497-500.
137. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011, 377:942-955.
138. Cognition and MND Motor Neurone Disease Association, (accessed Jan 16, 2013). http://www.mndassociation.org/Resources/MNDA/Life%20with%20MND/Cognition_andMND.pdf.
139. ALS and cognitive changes: a guide for patients and families ALS Association, (accessed Jan 16, 2013). http://www.alsa.org/als-care/resources/publications-videos/factsheets/cogntive-changes-family-html.
140. A manual for people living with ALS ALS Society of Canada, (accessed Jan 16, 2013). http://www.als.ca/sites/default/files/files/ALS%20Manual/2012%20Manual%20People%20Living%20With%20ALS%20-%20ENGLISH%20Final.pdf.